| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 13/02/2018 | 21:59 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 15/02/2017 | 21:12 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 02/08/2016 | 22:02 | Edgar (US Regulatory) | Amended Termination of Registration of a Class of Security Under Section 12(b) (15-12b/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 02/08/2016 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 27/07/2016 | 23:50 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 22/07/2016 | 17:30 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 15/07/2016 | 22:50 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 13/07/2016 | 19:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 22:15 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 22:10 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 22:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 15:14 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 14:43 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 14:41 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 12/07/2016 | 07:50 | PR Newswire (US) | Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celat... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 27/06/2016 | 06:10 | PR Newswire (US) | Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 17/06/2016 | 14:00 | PR Newswire (US) | Drugs - Generic Stocks Technical Data - Allergan, Mylan, Horizon Pharma, and Celator Pharma | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 15/06/2016 | 23:06 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 14/06/2016 | 13:00 | PR Newswire (US) | Celator Pharmaceuticals® Announces Positive Results in Patients with FLT3 Mutation from the Phase 3 Trial in High-Risk Acute... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 14/06/2016 | 01:00 | Business Wire | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourage... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 10/06/2016 | 22:07 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 10/06/2016 | 22:03 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 06/06/2016 | 13:00 | PR Newswire (US) | Celator Pharmaceuticals® Presented Phase 3 Trial Results in Patients with High-Risk Acute Myeloid Leukemia Demonstrating VYX... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 04/06/2016 | 00:21 | PR Newswire (US) | Celator Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of CPXX Shareholders | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 02/06/2016 | 19:21 | Business Wire | CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to J... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 02/06/2016 | 15:11 | PR Newswire (US) | SHAREHOLDER ALERT: Law Offices of Marc S. Henzel Announces Investigation into the proposed sales and mergers of American Capi... | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 01/06/2016 | 17:18 | Business Wire | CELATOR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 01/06/2016 | 15:26 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 31/05/2016 | 23:26 | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |
| 31/05/2016 | 23:04 | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Celator Pharmaceuticals, Inc. | NASDAQ:CPXX | Celator Pharmaceuticals Inc. (MM) |